Friday, October 31, 2008 - 13:07 in Health & Medicine
Researchers at the Indiana University School of Medicine report that the anti-cancer drug Gleevec holds out promise to become the first effective treatment for neurofibromatosis, a genetic disease that has resisted treatments until now...
- Gleevec holds potential as first drug to successfully treat neurofibromatosis, IU scientists reportThu, 30 Oct 2008, 16:08:36 EDT
- Researchers identify mechanism, possible drug treatment for tumors in neurofibromatosisThu, 30 Oct 2008, 16:08:39 EDT
- Protein predicts Gleevec resistance in gastrointestinal tumorsFri, 16 May 2008, 11:07:39 EDT
- Cancer drug shows promise for treating sclerodermaMon, 28 Mar 2011, 9:33:01 EDT
- Finding key to cancer drug Gleevec's limitationsWed, 5 Aug 2009, 9:57:46 EDT